Apoptosis in the nervous system

Nature

Volumn 407, Issue 6805, 2000, Pages 802-809

  Yuan, Junying ^b   Yankner, Bruce A ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; AMYLOID; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; NEUROTROPHIN; PHOSPHATIDYLINOSITOL 3 KINASE; POLYGLUTAMINE; PROTEIN BCL 2; PROTEIN KINASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; BRAIN DEVELOPMENT; BRAIN ISCHEMIA; DEGENERATIVE DISEASE; HUMAN; NERVE CELL NECROSIS; NERVOUS SYSTEM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ADULT; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; APOPTOSIS; BRAIN; HUMANS; MUTATION; NERVE GROWTH FACTORS; NERVOUS SYSTEM; NEURONS; SUPEROXIDE DISMUTASE;

EID: 0034641936     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35037739     Document Type: Review

References (101)

1. Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation
2. Genetics of programmed cell death in C. elegans past, present and future
3. Prevention of vertebrate neuronal death by the crmA gene
4. Bal-2 gene family in the nervous system
5. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene
6. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia
7. Neonatal motoneurons overexpressing the bcl-2 protooncogene in transgenic mice are protected from axotomy-induced cell death
8. Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease
9. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair
10. Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development
11. bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death
12. Massive cell death of immature hematopoietic cell and neurons in Bcl-x-deficient mice
13. BAX is required for neuronal death after trophic facto deprivation and during development
14. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3
15. Apaf1 (CED-4 homolog) regulates programmed call death in mammalian development
16. Proteases to die for
17. Cytochrome c and dATp-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
18. Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions
19. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β
20. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice
21. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspasce 9
22. Structural and functional properties of the TRK family of neurotrophin receptors
23. Phosphoinositide kinases
24. Regulation of the Ras signaling pathway by GTPase-activating protein in Pc12 cells
25. Activated phosphatidylinositol 3-kinase and Akt kinase promote survival of superior cervical neurons
26. Cellular survival: A play in three Akts
27. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death
28. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
29. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor
30. CREB is a regulatory target for the protein kinase Akt/PKB
31. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons
32. Induction of NF-κB by the Akt/PKB kinase
33. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and-independent mechanisms
34. 2+ determine nerve growth factor dependence of sympathetic ganglion cells
35. Neuronal activity-dependent cell survival mediated by transcription factor MEF2
36. Depolarization and neurotrophins converge on the phosphatidylinositol 3-kinase-Akt pathway to synergistically regulate neuronal survival
37. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
38. Altered gene expression in neurons during programmed cell death: Identification of c-jun as necessary for neuronal apoptosis
39. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death
40. The cell death-promoting gene DP5, which interacts with the BCL2 family, is induced during neuronal apoptosis following exposure to amyloid beta protein
41. BAX translocation is a critical event in neuronal apoptosis: Regulation by neuroprotectants, BCL-2, and caspases
42. Evidence of a novel event during neuronal death: Development of competence-to-die in response to cytoplasmic cytochrome c
43. Signalling through the neurotrophin receptor p75NTR
44. Induction of cell death by endogenous nerve growth factor through its p75 receptor
45. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75
46. The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occurring sympathetic neuron death
47. TrkB signalling inhibits p75-mediated apoptosis induced by nerve growth factor in embryonic proprioceptive neurons
48. Induction of DNA fragmentation after 10 to 120 minutes of focal cerebral ischemia in rats
49. Apoptosis and necrosis after reversible focal ischemia: An in situ DNA fragmentation analysis
50. Activation and cleavage of caspase- 3 in apoptosis induced by experimental cerebral ischemia
51. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis
52. Immunohistochemcial evidence for apoptosis in Alzheimer's disease
53. In situ labeling of dying cortical neurons in normal aging and in Alzheimer's disease: Correlations with senile plaques and disease progression
54. Alzheimer's disease: Genotypes, phenotypes and treatments
55. Mechanisms of neuronal degeneration in Alzheimer's disease
56. Aging renders the brain vulnerable to amyloid β-protein neurotoxcity
57. Hydrogen peroxide mediates amyloid β protein toxicity
58. Calcium-destablizing and neurodegenerative effect of aggregate beta-amyloid peptide are attenuated by basic FGF
59. Apoptosis is induced by β-amyloid in cultured central nervous system neurons
60. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
61. Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease
62. Amyloid-β interacts with the amyloid precursor protein: A potential toxic mechansim in Alzheimer's disease
63. Aggegated amyloid-beta protein induces cortical neuronal apoptosis and concomitant 'apoptotic' pattern of gene induction
64. Caspase-2 mediates neuronal cell death induced by beta-amyloid
65. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
66. Candidate gene for chromosome 1 familial Alzheimer's disease locus
67. Alzheimer's disease: Genetic studies and transgenic models
68. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
69. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity
70. Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1
71. Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease
72. Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia
73. Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation
74. A role of microglia and host prion protein in neurotoxicity of prion protein fragment
75. Microglia as mediators of inflammatory and degenerative diseases
76. Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type I isolates: Evidence for a role of the envelope
77. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo
78. Polyglutamines, nuclear inclusions and neurodegeneration
79. Aggregation of huntington in neuronal intranuclear inclusions and dystrophic neurites in brain
80. Reversing neurodegeneration: A promise unfolds
81. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
82. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
83. Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice
84. Caspase-8 is required for cell death induced by expanded polyglutamine repeats
85. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease
86. Neuropathological classification of Huntington's diesease
87. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
88. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease
89. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
90. From Charcot to SOD 1: Mechanisms of selective motor neuron death in ALS
91. Mutations associated with amyotrophic lateral sclerosis covert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: Studies in yeast and neural cells
92. Caspase-1 is activated in neuron1 cells and tissue with amytrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase
93. Bcl-2: Prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis
94. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model
95. Inhibition of ICE slows ALS in mice
96. Mice deficient in interleukin- 1 converting enzyme are resistant to neonatal hypoxic-isehemic brain damage
97. Differential requirement for caspase 9 in apoptotic pathways in vivo
98. Neurodegenerative tauopathies: Human disease and transgenic mouse models
99. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration